Dietary compounds which protect against heterocyclic amines

Acrylamide and Other Hazardous Compounds in Heat-Treated Foods

Volumn , Issue , 2006, Pages 425-458

  Knasmûller, Siegfried ^a   Holzl C ^a   Bichler, J ^a   Nersesyan, A ^a   Ehrlich, V A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903656129     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-84569-011-3.50018-5     Document Type: Chapter

References (183)

1. Sugimura T., Kawachi T., Nagao M., Yahagi T., Seino T., Okamoto T., Shudo K., Kosuge T., Tsuji K., Wakabayashi K., Iitaka Y., Itai A. Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products. Proc Jpn Acad 1977, 53:58-61.
2. Kada T., Morita K., Inoue T. Anti-mutagenic action of vegetable factor(s) on the mutagenic principle of tryptophan pyrolysate. Mutat Res 1978, 53:351-353.
3. Schwab C.E., Huber W.W., Parzefall W., Hietsch G., Kassie F., Schulte-Hermann R., Knasmûller S. Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit Rev Toxicol 2000, 30:1-69.
4. Morita K., Hara M., Kada T. Studies on natural desmutagens: screening for vegetable and fruit factors active in inactivation of mutagenic pyrolysis products from amino acids. Agric Biol Chem 1978, 42:1235-1238.
5. Wattenberg L.W. Chemoprevention of cancer. Cancer Res 1985, 45:1-8.
6. Wattenberg L.W. Inhibition of carcinogenesis by naturally-occuring and synthetic compounds. Antimutagenesis and Anticarcinogenesis Mechanisms II 1990, 155-1566. Plenum Press, New York. Y. Kuroda, D.M. Shankel, M.D. Waters (Eds.).
7. De Flora S., Ramel C. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res 1988, 202:285-306.
8. De Flora S., Ramel C. Classification of mechanisms of inhibitors of mutagenesis and carcinogenesis. Basic Life Sci 1990, 52:461-462.
9. Guo D., Schut H.A., Davis C.D., Snyderwine E.G., Bailey G.S., Dashwood R.H. Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 1995, 16:2931-2937.
10. Dashwood R., Liew C. Chlorophyllin-enhanced excretion of urinary and fecal mutagens in rats given 2-amino-3-methylimidazo[4,5-f]quinoline. Environ Mol Mutagen 1992, 20:199-205.
11. Vkse R., Mjelva B.B., Klungsoyr L. Reversible binding of the cooked food mutagen MeIQx to lignin-enriched preparations from wheat bran. Food Chem Toxicol 1992, 30:239-246.
12. Ryden P., Robertson J.A. The effects of pH and bile salts on the binding of MeIQx to wheat bran fibre. Mutat Res 1996, 351:45-52.
13. Sjodin P., Nyman M., Nielsen L.L., Wallin H., Jägerstad M. Effect of dietary fiber on the disposition and excretion of a food carcinogen (2-14C-labeled MeIQx) in rats. Nutr Cancer 1992, 17:139-151.
14. Knasmûller S., Steinkellner H., Hirschl A.M., Rabot S., Nobis E.C., Kassie F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat Res 2001, 480-481:129-138.
15. Dashwood R.H., Xu M. The disposition and metabolism of 2-amino-3-methylimidazo-[4,5-f]quinoline in the F344 rat at high versus low doses of indole-3-carbinol. Food Chem Toxicol 2003, 41:1185-1192.
16. Muto S., Fujita K., Yamazaki Y., Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001, 479:197-206.
17. Edenharder R., Worf-Wandelburg A., Decker M., Platt K.L. Anti-mutagenic effects and possible mechanisms of action of vitamins and related compounds against genotoxic heterocyclic amines from cooked food. Mutat Res 1999, 444:235-248.
18. Barcelo S., Mace K., Pfeifer A.M., Chipman J.K. Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazo[4,5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane. Mutat Res 1998, 402:111-120.
19. Hammons G.J., Fletcher J.V., Stepps K.R., Smith E.A., Balentine D.A., Harbowy M.E., Kadlubar F.F. Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes. Nutr Cancer 1999, 33:46-52.
20. Miranda C.L., Yang Y.H., Henderson M.C., Stevens J.F., Santana-Rios G., Deinzer M.L., Buhler D.R. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metab Dispos 2000, 28:1297-1302.
21. Bear W.L., Teel R.W. Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer Res 2000, 20:3609-3614.
22. Xu M., Dashwood R.H. Chemoprevention studies of heterocyclic amine-induced colon carcinogenesis. Cancer Lett 1999, 143:179-183.
23. Liew C., Schut H.A., Chin S.F., Pariza M.W., Dashwood R.H. Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 1995, 16:3037-3043.
24. Hasaniya N., Youn K., Xu M., Hernaez J., Dashwood R. Inhibitory activity of green and black tea in a free radical-generating system using 2-amino-3-methylimidazo[4,5-f]quinoline as substrate. Jpn J Cancer Res 1997, 88:553-558.
25. Mizuno M., Toda M., Ueno N., Danno G., Anazawa K., Natake M. Desmutagenicity of a dibenzofuran-quinone derivative toward the mutagenicity of Trp-P-2. Agric Biol Chem 1989, 53:959.
26. Lewis A.J., Walle U.K., King R.S., Kadlubar F.F., Falany C.N., Walle T. Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. Carcinogenesis 1998, 19:2049-2053.
27. Hölzl C. Schutzeffekte von Kohlsprossen vor freien Sauerstoffradikalen und heterozyklischen Aminen 2004, Institute of Cancer Research, University of Vienna, Vienna.
28. Hernaez J., Xu M., Dashwood R. Effects of tea and chlorophyllin on the mutagenicity of N-hydroxy-IQ: studies of enzyme inhibition, molecular complex formation, and degradation/scavenging of the active metabolites. Environ Mol Mutagen 1997, 30:468-474.
29. Edenharder R., Sager J.W., Glatt H., Muckel E., Platt K.L. Protection by beverages, fruits, vegetables, herbs, and flavonoids against genotoxicity of 2-acetylaminofluorene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in metabolically competent V79 cells. Mutat Res 2002, 521:57-72.
30. Yu T.W., Xu M., Dashwood R.H. Antimutagenic activity of spearmint. Environ Mol Mutagen 2004, 44:387-393.
31. Huber W.W., McDaniel L.P., Kaderlik K.R., Teitel C.H., Lang N.P., Kadlubar F.F. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res 1997, 376:115-122.
32. Santana-Rios G., Orner G.A., Xu M., Izquierdo-Pulido M., Dashwood R.H. Inhibition by white tea of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced colonic aberrant crypts in the F344 rat. Nutr Cancer 2001, 41:98-103.
33. Rao C.V., Rivenson A., Zang E., Steele V., Kelloff G., Reddy B.S. Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz. Cancer Res 1996, 56:3395-3398.
34. Kassie F., Rabot S., Uhl M., Huber W., Qin H.M., Helma C., Schulte-Hermann R., Knasmûller S. Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis 2002, 23:1155-1161.
35. Xu M., Bailey A.C., Hernaez J.F., Taoka C.R., Schut H.A., Dashwood R.H. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 1996, 17:1429-1434.
36. Sanyal R., Darroudi F., Parzefall W., Nagao M., Knasmûller S. Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis 1997, 12:297-303.
37. Sato T., Nishino H., Nagase H., Nikawa M., Kito H. Bio-antimutagen detection method with wind spot test by. Drosophila meanogaster. Jpn J Toxicol Environ Health 1994, 40:498-503.
38. Zhang X.B., Ohta Y. Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates. Mutat Res 1993, 298:247-253.
39. Dashwood R.H., Xu M., Orner G.A., Horio D.T. Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidaz. Eur J Cancer Prev 2001, 10:139-145.
40. Xu M., Orner G.A., Bailey G.S., Stoner G.D., Horio D.T., Dashwood R.H. Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1,2-dimethylhydrazine or 2-amino-3-methyl-imidazo. Carcinogenesis 2001, 22:309-314.
41. Nakatsugi S., Ohta T., Kawamori T., Mutoh M., Tanigawa T., Watanabe K., Sugie S., Sugmura T., Wakabayashi K. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats. Jpn J Cancer Res 2000, 91:886-892.
42. Collett G.P., Robson C.N., Mathers J.C., Campbell F.C. Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis 2001, 22:821-825.
43. Dashwood R. Chlorophylls as anticarcinogens (review). Int J Oncol 1997, 10:721-727.
44. Muckel E., Frandsen H., Glatt H.R. Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food Chem Toxicol 2002, 40:1063-1068.
45. Glatt H., Pabel U., Meinl W., Frederiksen H., Frandsen H., Muckel E. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9h-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes. Carcinogenesis 2004, 25:801-807.
46. Cavin C., Mace K., Offord E.A., Schilter B. Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Food Chem Toxicol 2001, 39:549-556.
47. Cavin C., Bezencon C., Guignard G., Schilter B. Coffee diterpenes prevent benzo[a]pyrene genotoxicity in rat and human culture systems. Biochem Biophys Res Commun 2003, 306:488-495.
48. Huber W.W., Teitel C.H., Coles B.F., King R.S., Wiese F.W., Kaderlik K.R., Casciano D.A., Shaddock J.G., Mulder G.J., Ilett K.F., Kadlubar F.F. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ Mol Mutagen 2004, 44:265-276.
49. Huber W.W., Prustomersky S., Delbanco E., Uhl M., Scharf G., Turesky R.J., Thier R., Schulte-Hermann R. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch Toxicol 2002, 76:209-217.
50. Dashwood R.H., Fong A.T., Williams D.E., Hendricks J.D., Bailey G.S. Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res 1991, 51:2362-2365.
51. Kim D.J., Han B.S., Ahn B., Hasegawa R., Shirai T., Ito N., Tsuda H. Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis 1997, 18:377-381.
52. Kang J.S., Kim D.J., Ahn B., Nam K.T., Kim K.S., Choi M., Jang D.D. Post-initiation treatment of Indole-3-carbinol did not suppress N-methyl-N-nitrosourea induced mammary carcinogenesis in rats. Cancer Lett 2001, 169:147-154.
53. Kassie F., Uhl M., Rabot S., Grasl-Kraupp B., Verkerk R., Kundi M., Chabicovsky M., Schulte-Hermann R., Knasmûller S. Chemo-prevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis 2003, 24:255-261.
54. Graf U., Wild D., Wurgler F.E. Genotoxicity of 2-amino-3-methyl-imidazo 4,5-f]quinoline (IQ) and related compounds in Drosophila. Mutagenesis 1992, 7:145-149.
55. Knasmûller S., Steinkellner H., Majer B.J., Nobis E.C., Scharf G., Kassie F. Search for dietary antimutagens and anticarcinogens: methodological aspects and extrapolation problems. Food Chem Toxicol 2002, 40:1051-1062.
56. Yu Z., Xu M., Santana-Rios G., Shen R., Izquierdo-Pulido M., Williams D.E., Dashwood R.H. A comparison of whole wheat, refined wheat and wheat bran as inhibitors of heterocyclic amines in the Salmonella mutagenicity assay and in the rat colonic aberrant crypt focus assay. Food Chem Toxicol 2001, 39:655-665.
57. Rutten B., Gocke E. The 'antimutagenic' effect of cinnamaldehyde is due to a transient growth inhibition. Mutat Res 1988, 201:97-105.
58. Konczak-Islam I., Yoshimoto M., Hou D.X., Terahara N., Yamakawa O. Potential chemopreventive properties of anthocyanin-rich aqueous extracts from in vitro produced tissue of sweetpotato (Ipomoea batatas L.). J Agric Food Chem 2003, 51:5916-5922.
59. Edenharder R., Keller G., Platt K.L., Unger K.K. Isolation and characterization of structurally novel antimutagenic flavonoids from spinach. (Spinacia oleracea). J Agric Food Chem 2001, 49:2767-2773.
60. Nakasugi T., Nakashima M., Komai K. Antimutagens in gaiyou (Artemisia argyi levl. et vant). J Agric Food Chem 2000, 48:3256-3266.
61. Takahashi A., Matsuoka H., Yamada K., Uda Y. Characterization of antimutagenic mechanism of 3-allyl-5-substituted 2-thiohydantoins against 2-amino-3-methylimidazo[4,5-f]quinoline. Food Chem Toxicol 2005, 43:521-528.
62. Trakoontivakorn G., Nakahara K., Shinmoto H., Takenaka M., Onishikameyama M., Ono H., Yoshida M., Nagata T., Tsushida T. Structural analysis of a novel antimutagenic compound, 4-Hydroxypanduratin A, and the antimutagenic activity of flavonoids in a Thai spice, fingerroot (Boesenbergia pandurata Schult.) against mutagenic heterocyclic amines. J Agric Food Chem 2001, 49:3046-3050.
63. Yoshimoto M., Yahara S., Okuno S., Islam M.S., Ishiguro K., Yamakawa O. Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweetpotato (Ipomoea batatas L.) leaf. Biosci Biotechnol Biochem 2002, 66:2336-2341.
64. Yoshimoto M., Okuno S., Yamaguchi M., Yamakawa O. Antimutagenicity of deacylated anthocyanins in purple-fleshed sweetpotato. Biosci Biotechnol Biochem 2001, 65:1652-1655.
65. Amantana A., Santana-Rios G., Butler J.A., Xu M., Whanger P.D., Dashwood R.H. Antimutagenic activity of selenium-enriched green tea toward the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline. Biol Trace Elem Res 2002, 86:177-191.
66. Deguchi T., Shohara S., Ohba R., Ueda S. Effects of pH and light on the storage stability of the purple pigment, hordeumin, from uncooked barley bran fermented broth. Biosci Biotechnol Biochem 2000, 64:2236-2239.
67. Knasmûller S., Stehlik G., Mohn G. Studies on the metabolic activation of diethanolnitrosamine in animal-mediated and in vitro assays using Escherichia coli K-12 343/113 as an indicator. J Cancer Res Clin Oncol 1986, 112:266-271.
68. Mori Y., Koide A., Tatematsu K., Sugie S., Mori H. Effects of alpha-naphthyl isothiocyanate and a heterocyclic amine, PhIP, on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver. Mutagenesis 2005, 20:15-22.
69. Montgomery B.A., Murphy J., Chen J.J., Desai V.G., McGarrity L., Morris S.M., Casciano D.A., Aidoo A. Mutagenicity of food-derived carcinogens and the effect of antioxidant vitamins. Nutr Cancer 2002, 43:103-110.
70. Anderson D., Dobrzynska M.M., Basaran N., Basaran A., Yu T.W. Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm. Mutat Res 1998, 402:269-277.
71. Anderson D., Basaran N., Dobrzynska M.M., Basaran A.A., Yu T.W. Modulating effects of flavonoids on food mutagens in human blood and sperm samples in the comet assay. Teratog Carcinog Mutagen 1997, 17:45-58.
72. Edenharder R., Kerkhoff G., Dunkelberg H. Effects of beta-carotene, retinal, riboflavin, alpha-tocopherol and vitamins C and K1 on sister-chromatid exchanges induced by 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and cyclophosphamide in human lymphocyte cultures. Food Chem Toxicol 1998, 36:897-906.
73. Uhl M., Helma C., Knasmûller S. Single-cell gel electrophoresis assays with human-derived hepatoma (Hep G2) cells. Mutat Res 1999, 441:215-224.
74. Uhl M., Helma C., Knasmûller S. Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells. Mutat Res 2000, 468:213-225.
75. Natarajan A.T., Darroudi F. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis 1991, 6:399-403.
76. Knasmûller S., Schwab C.E., Land S.J., Wang C.Y., Sanyal R., Kundi M., Parzefall W., Darroudi F. Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells. Mutagenesis 1999, 14:533-540.
77. Majer B.J., Kassie F., Sasaki Y., Pfau W., Glatt H., Meinl W., Darroudi F., Knasmûller S. Investigation of the genotoxic effects of 2-amino-9H-pyrido[2,3-b]indole in different organs of rodents and in human derived cells. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 802:167-173.
78. Knasmûller S., Mersch-Sundermann V., Kevekordes S., Darroudi F., Huber W.W., Hölzl C., Bichler J., Majer B.J. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 2004, 198:315-328.
79. Mersch-Sundermann V., Knasmûller S., Wu X.J., Darroudi F., Kassie F. Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 2004, 198:329-340.
80. Knasmûller S., Parzefall W., Sanyal R., Ecker S., Schwab C., Uhl M., Mersch-Sundermann V., Williamson G., Hietsch G., Langer T., Darroudi F., Natarajan A.T. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res 1998, 402:185-202.
81. Uhl M., Ecker S., Kassie F., Lhoste E., Chakraborty A., Mohn G., Knasmûller S. Effect of chrysin, a flavonoid compound, on the mutagenic activity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and benzo(a)pyrene (B(a)p) in bacterial and human hepatoma (HepG2) cells. Arch Toxicol 2003, 11:477-484.
82. Majer B.J., Hofer E., Cavin C., Lhoste E., Uhl M., Glatt H.R., Meinl W., Knasmûller S. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). Food Chem Toxicol 2005, 43:433-441.
83. Iarc W.H.O. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some natural occuring substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mykotoxines. Heterocyclic aromatic amines 1993, 229-242. IARC, Lyon. International Agency for Research on Cancer, W.H.O. (Ed.).
84. Bu-Abbas A., Clifford M.N., Walker R., Ioannides C. Marked anti-mutagenic potential of aqueous green tea extracts: mechanism of action. Mutagenesis 1994, 9:325-331.
85. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000, 35:206-221.
86. Kassie F., Rabot S., Uhl M., Huber W., Qin H.M., Helma C., Schulte-Hermann R., Knasmûller S. Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis 2002, 23:1155-1561.
87. Humblot C., Kassie F., Nugon-Baudon L., Knasmûller K., Lhoste E.F. Diet modulates the genotoxicity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in rats associated with a human faecal flora. IARC Sci Publ 2002, 156:417-418.
88. Zsivkovits M., Fekadu K., Sontag G., Nabinger U., Huber W.W., Kundi M., Chakraborty A., Foissy H., Knasmûller S. Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains. Carcinogenesis 2003, 24:1913-1918.
89. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci USA 1991, 88:7958-7962.
90. De Boer J.G. Protection by dietary compounds against mutation in a transgenic rodent. J Nutr 2001, 131:3082S-3086S.
91. Yang H., Stuart G.R., Glickman B.W., De Boer J.G. Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione. Nutr Cancer 2001, 39:259-266.
92. Williams G.M. Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity. IARC Sci Publ 1999, 185-202.
93. Ehrlich V.A., Huber W., Grasl-Kraupp B., Nersesyan A., Knasmûller S. Use of preneoplastic lesions in colon and liver in experimental oncology. Radiology and Oncology 2004, 38:205-216.
94. Ishiguro Y., Ochiai M., Sugimura T., Nagao M., Nakagama H. Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility. Carcinogenesis 1999, 20:1063-1068.
95. Hagiwara A., Miyashita K., Nakanishi T., Sano M., Tamano S., Kadota T., Koda T., Nakamura M., Imaida K., Ito N., Shirai T. Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine. Cancer Lett 2001, 171:17-25.
96. Hagiwara A., Yoshino H., Ichihara T., Kawabe M., Tamano S., Aoki H., Koda T., Nakamura M., Imaida K., Ito N., Shirai T. Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. J Toxicol Sci 2002, 27:57-68.
97. Corpet D.E., Pierre F. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 2003, 12:391-400.
98. 2 at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun 2002, 296:584-588.
99. Tavan E., Cayuela C., Antoine J.M., Trugnan G., Chaugier C., Cassand P. Effects of dairy products on heterocyclic aromatic amine-induced rat colon carcinogenesis. Carcinogenesis 2002, 23:477-483.
100. Uhl M., Kassie F., Rabot S., Grasl-Kraupp B., Chakraborty A., Laky B., Kundi M., Knasmûller S. Effect of common Brassica vegetables (Brussels sprouts and red cabbage) on the development of preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver and colon of Fischer 344 rats. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 802:225-230.
101. Tsuda H., Sekine K., Uehara N., Takasuka N., Moore M.A., Konno Y., Nakashita K., Degawa M. Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats. Cancer Lett 1999, 143:229-234.
102. Mori H., Sugie S., Rahman W., Suzui N. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced mammary carcinogenesis in rats. Cancer Lett 1999, 143:195-198.
103. Hagiwara A., Boonyaphiphat P., Tanaka H., Kawabe M., Tamano S., Kaneko H., Matsui M., Hirose M., Ito N., Shirai T. Organ-dependent modifying effects of caffeine, and two naturally occurring antioxidants alpha-tocopherol and n-tritriacontane-16,18-dione, on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary and colonic carcinogenesis in female F344 rats. Jpn J Cancer Res 1999, 90:399-405.
104. Hirose M., Yamaguchi T., Lin C., Kimoto N., Futakuchi M., Kono T., Nishibe S., Shirai T. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 2000, 155:79-88.
105. Guo D., Horio D.T., Grove J.S., Dashwood R.H. Inhibition by chlorophyllin of 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumorigenesis in the male F344 rat. Cancer Lett 1995, 95:161-165.
106. Dashwood R.H. Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis. J Biochem Mol Biol 2003, 36:35-42.
107. Steinkellner H., Rabot S., Freywald C., Nobis E., Scharf G., Chabicovsky M., Knasmûller S., Kassie F. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 2001, 480-481:285-297.
108. Yoxall V.R., Bishop J., Ioannides C. Effect of black tea intake on the excretion of mutagens in the urine of volunteers taking a beef meal. Cancer Epidemiol Biomarkers Prev 2004, 13:2196-2202.
109. Frandsen H., Frederiksen H., Alexander J. 2-Amino-1-methyl-6-(5-hydroxy-)phenylimidazo[4,5-b]pyridine (5-OH-PhIP), a biomarker for the genotoxic dose of the heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Food Chem Toxicol 2002, 40:1125-1130.
110. Walters D.G., Young P.J., Agus C., Knize M.G., Boobis A.R., Gooderham N.J., Lake B.G. Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Carcinogenesis 2004, 25:1659-1669.
111. Dashwood R.H. Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: an 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models. Mutat Res 2002, 511:89-112.
112. Tsuda H., Uehara N., Iwahori Y., Asamoto M., Iigo M., Nagao M., Matsumoto K., Ito M., Hirono I. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn J Cancer Res 1994, 85:1214-1219.
113. Uehara N., Iwahori Y., Asamoto M., Baba-Toriyama H., Iigo M., Ochiai M., Nagao M., Nakayama M., Degawa M., Matsumoto K., Hirono I., Beppu H., Fujita K., Tsuda H. Decreased levels of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with beta-carotene, alpha-tocopherol and freeze-dried aloe. Jpn J Cancer Res 1996, 87:342-348.
114. Verhoeven D.T., Verhagen H., Goldbohm R.A., Van Den Brandt P.A., Van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 1997, 103:79-129.
115. Glatt H. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 2000, 129:141-170.
116. Glatt H.R. An overview of bioactivation of chemical carcinogens. Biochem Soc Trans 2000, 28:1-6.
117. Glatt H., Engelke C.E., Pabel U., Teubner W., Jones A.L., Coughtrie M.W., Andrae U., Falany C.N., Meinl W. Sulfotransferases: genetics and role in toxicology. Toxicol Lett 2000, 112-113:341-348.
118. Glatt H., Meinl W. Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn Schmiedebergs Arch Pharmacol 2004, 369:55-68.
119. He Y.H., Smale M.H., Schut H.A. Chemopreventive properties of indole-3-carbinol (13C): inhibition of DNA adduct formation of the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), in female F344 rats. J Cell Biochem Suppl 1997, 27:42-51.
120. Xu M., Schut H.A., Bjeldanes L.F., Williams D.E., Bailey G.S., Dashwood R.H. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: dose-response studies in the rat colon. Carcinogenesis 1997, 18:2149-2153.
121. He Y.H., Schut H.A. Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3-methylimidazo[4,5-f]quinoline by dietary indole-3-carbinol in female rats. J Biochem Mol Toxicol 1999, 13:239-247.
122. Sreekumar O., Hosono A. The heterocyclic amine binding receptors of Lactobacillus gasseri cells. Mutat Res 1998, 421:65-72.
123. Zhang X.B., Ohta Y. In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice. J Dairy Sci 1991, 74:752-757.
124. Knasmûller S., Murkovic M., Pfau W., Sontag G. Heterocyclic aromatic amines - still a challenge for scientists. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 802:1-2.
125. Hayatsu H., Hayatsu T. Suppressing effect of Lactobacillus casci administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 1993, 73:173-179.
126. Lidbeck A., Övervik E., Rafter J., Nard C., Gustavsson J. Effects of lactobacillus acidophilus on mutagen excretion in feces and urine of humans. Microbiol. Environ. Health 1992, 5:59-67.
127. Ohta T., Nakatsugi S., Watanabe K., Kawamori T., Ishikawa F., Morotomi M., Sugie S., Toda T., Sugimura T., Wakabayashi K. Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 2000, 21:937-941.
128. Dashwood R.H., Xu M., Hernaez J.F., Hasaniya N., Youn K., Razzuk A. Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc Soc Exp Biol Med 1999, 220:239-243.
129. Takahashi E., Marczylo T.H., Watanabe T., Nagai S., Hayatsu H., Negishi T. Preventive effects of anthraquinone food pigments on the DNA damage induced by carcinogens in Drosophila. Mutat Res 2001, 480-481:139-145.
130. Smith C.J., Perfetti T.A., Rumple M.A., Rodgman A., Doolittle D.J. 'IARC group 2A Carcinogens' reported in cigarette mainstream smoke. Food Chem Toxicol 2000, 38:371-383.
131. Kinae N., Masuda H., Shin I.S., Furugori M., Shimoi K. Functional properties of wasabi and horseradish. Biofactors 2000, 13:265-269.
132. McArdle N.J., Clifford M.N., Ioannides C. Consumption of tea modulates the urinary excretion of mutagens in rats treated with IQ. Role of caffeine. Mutat Res 1999, 441:191-203.
133. Embola C.W., Weisburger J.H., Weisburger M.C. Urinary excretion of N-OH-2-amino-3-methylimidazo[4,5-f]quinoline-n-glucuronide in F344 rats is enhanced by green tea. Carcinogenesis 2001, 22:1095-1098.
134. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 1999, 436:69-97.
135. Lambert J.D., Yang C.S. Mechanisms of cancer prevention by tea constituents. J Nutr 2003, 133:3262S-3267S.
136. Hirose M., Hasegawa R., Kimura J., Akagi K., Yoshida Y., Tanaka H., Miki T., Satoh T., Wakabayashi K., Ito N., et al. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 1995, 16:3049-3055.
137. Hayatsu H., Arimoto S., Negishi T. Dietary inhibitors of mutagenesis and carcinogenesis. Mutat Res 1988, 202:429-446.
138. Catterall F., Copeland E., Clifford M.N., Ioannides C. Contribution of theafulvins to the antimutagenicity of black tea: their mechanism of action. Mutagenesis 1998, 13:631-636.
139. Bichler J. Schutzeffekte von Kaffee vor freien Sauerstoffradikalen und heterozyklischen Aminen 2005, Institute of Cancer Research, University of Vienna, Vienna.
140. Weisburger J.H., Dolan L., Pittman B. Inhibition of PhIP mutagenicity by caffeine, lycopene, daidzein, and genistein. Mutat Res 1998, 416:125-128.
141. Alldrick A.J., Brennan-Craddock W.E., Rowland I.R. Dietary caffeine reduces the genotoxicity of MeIQx in the host-mediated assay in mice. Nutr Cancer 1995, 24:143-150.
142. Murray B.P., Bobbis A.R., De La Torre R., Segura J., Davis D.S. Inhibition of dietary mutagens activation by methylxanthines. Biochem Soc Trans 1988, 16:620-625.
143. Arimoto-Kobayashi S., Sugiyama C., Harada N., Takeuchi M., Takemura M., Hayatsu H. Inhibitory effects of beer and other alcoholic beverages on mutagenesis and DNA adduct formation induced by several carcinogens. J Agric Food Chem 1999, 47:221-230.
144. Arimoto-Kobayashi S., Takata J., Nakandakari N., Fujioka R., Okamoto K., Konuma T. Inhibitory effects of heterocyclic amine-induced DNA adduct formation in mouse liver and lungs by beer. J Agric Food Chem 2005, 53:812-815.
145. Nozawa H., Tazumi K., Sato K., Yoshida A., Takata J., Arimoto-Kobayashi S., Kondo K. Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon. Mutat Res 2004, 559:177-187.
146. Filipic M., Plazar J., Fatur T., Kac J., Lah T.T., Milnaric A. Environment and human genetic disease - Causes, mechanisms and effects. Modulatory effect of xanthohumol on genotoxcity of heterocyclic amine (IQ). 2005, EEMS, Kos Island, Greece, 134.
147. Dashwood R.H. Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to rat liver DNA. Carcinogenesis 1992, 13:113-118.
148. Sarkar D., Sharma A., Talukder G. Chlorophyll and chlorophyllin as modifiers of genotoxic effects. Mutat Res 1994, 318:239-247.
149. Arimoto S., Hayatsu H. Role of hemin in the inhibition of mutagenic activity of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and other amino-azaarenes. Mutat Res 1989, 213:217-226.
150. Hasegawa R., Hirose M., Kato T., Hagiwara A., Boonyaphiphat P., Nagao M., Ito N., Shirai T. Inhibitory effect of chlorophyllin on PhIP-induced mammary carcinogenesis in female F344 rats. Carcinogenesis 1995, 16:2243-2246.
151. Guo D., Dashwood R. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA binding in rats given chlorophyllin: dose-response and time-course studies in the liver and colon. Carcinogenesis 1994, 15:763-766.
152. Takahashi E., Fujita K., Kamataki T., Arimoto-Kobayashi S., Okamoto K., Negishi T. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. Mutat Res 2002, 508:147-156.
153. Barnes W.S., Maiello J., Weisburger J.H. In vitro binding of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline to dietary fibers. J Natl Cancer Inst 1983, 70:757-760.
154. Harris P.J., Triggs C.M., Roberton A.M., Watson M.E., Ferguson L.R. The adsorption of heterocyclic aromatic amines by model dietary fibers with contrasting compositions. Chem Biol Interact 1996, 100:13-25.
155. Kato T., Takahashi S., Kkugawa K. Loss of heterocyclic amine mutagens by insoluble hemicellulose fiber and high-molecular-weight soluble polyphenolics of coffee. Mutat Res 1991, 246:169-178.
156. Ferguson L.R., Harris P.J. Studies on the role of specific dietary fibers in protection against colorectal cancer. Mutat Res 1996, 350:173-184.
157. Ferguson L.R., Harris P.J. Suberized plant cell walls suppress formation of heterocyclic amine-induced aberrant crypts in a rat model. Chem Biol Interact 1998, 114:191-209.
158. Helsby N.A., Zhu S., Pearson A.E., Tingle M.D., Ferguson L.R. Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymes. Mutat Res 2000, 454:77-88.
159. Kestell P., Zhao L., Zhu S., Harris P.J., Ferguson L.R. Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis 1999, 20:2253-2260.
160. Kestell P., Zhu S., Ferguson L.R. Mechanisms by which resistant starches and non-starch polysaccharide sources affect the metabolism and disposition of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 802:201-210.
161. Ferguson L.R., Zhu S., Kestell P. Contrasting effects of non-starch polysaccharide and resistant starch-based diets on the disposition and excretion of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), in a rat model. Food Chem Toxicol 2003, 41:785-792.
162. Humblot C., Lhoste E., Knasmuller S., Gloux K., Bruneau A., Bensaada M., Durao J., Rabot S., Andrieux C., Kassie F. Protective effects of Brussels sprouts, oligosaccharides and fermented milk towards 2-amino-3-methylimidazo[4,5-f]quinolme (IQ)-induced genotoxicity in the human flora associated F344 rat: role of xenobiotic metabolising enzymes and intestinal microflora. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 802:231-237.
163. Bruce W.R., Bird R. The concentration of bile acids in the fecal stream as a risk factor for colon cancer. Basic Life Sci 1986, 39:393-397.
164. Hayatsu H., Arimoto S., Togawa K., Makita M. Inhibitory effect of the ether extract of human feces on activities of mutagens: inhibition by oleic and linoleic acids. Mutat Res 1981, 81:287-293.
165. Knasmûller S., Beyene F.K., Parzefall W., Schulte-Hermann R. Influence of dietary factors on the genotoxic effects of cooked food mutagens. Arch Compl Environ Stud 1994, 6:75-80.
166. Josyula S., Schut H.A. Dietary omega-3 fatty acids as potential inhibitors of carcinogenesis: effect on DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice and rats. Food Chem Toxicol 1999, 37:287-296.
167. Zu H.X., Schut H.A. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adduct formation in CDF1 mice by heat-altered derivatives of linoleic acid. Food Chem Toxicol 1992, 30:9-16.
168. Schut H.A., Cummings D.A., Smale M.H., Josyula S., Friesen M.D. DNA adducts of heterocyclic amines: formation, removal and inhibition by dietary components. Mutat Res 1997, 376:185-194.
169. Okai Y., Higashi-Okai K., Nakamura S., Yano Y., Otani S. Suppressive effects of retinoids, carotenoids and antioxidant vitamins on heterocyclic amine-induced umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002). Mutat Res 1996, 368:133-140.
170. Busk L., Ahlborg U.G., Albanus L. Inhibition of protein pyrolysate mutagenicity by retinol (vitamin A). Food Chem Toxicol 1982, 20:535-539.
171. Ioannides C., Ayrton A.D., Keele A., Lewis D.F., Flatt P.R., Walker R. Mechanism of the in vitro antimutagenic action of retinol. Mutagenesis 1990, 5:257-262.
172. Hirose M., Nishikawa A., Shibutani M., Imai T., Shirai T. Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats. Environ Mol Mutagen 2002, 39:271-278.
173. Hirose M., Akagi K., Hasegawa R., Yaono M., Satoh T., Hara Y., Wakabayashi K., Ito N. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Carcinogenesis 1995, 16:217-221.
174. Hirose M., Takahashi S., Ogawa K., Futakuchi M., Shirai T. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis. Food Chem Toxicol 1999, 37:985-992.
175. Hikosaka A., Asamoto M., Hokaiwado N., Kato K., Kuzutani K., Kohri K., Shirai T. Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 2004, 25:381-387.
176. Kawabe M., Lin C., Kimoto N., Sano M., Hirose M., Shirai T. Modifying effects of propolis on MeIQx promotion of rat hepatocarcinogenesis and in a female rat two-stage carcinogenesis model after multiple carcinogen initiation. Nutr Cancer 2000, 37:179-186.
177. Chewonarin T., Kinouchi T., Kataoka K., Arimochi H., Kuwahara T., Vinitketkumnuen U., Ohnishi Y. Effects of roselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats. Food Chem Toxicol 1999, 37:591-601.
178. Verkerk R., Van Der Gaag M.S., Dekker M., Jongen W.M. Effects of processing conditions on glucosinolates in cruciferous vegetables. Cancer Lett 1997, 114:193-194.
179. Verkerk R., Dekker M. Glucosinolates and myrosinase activity in red cabbage (Brassica oleracea L. var. Capitata f. rubra DC.) after various microwave treatments. J Agric Food Chem 2004, 52:7318-7323.
180. Anzai N., Taniyama T., Nakandakari N., Sugiyama C., Negishi T., Hayatsu H., Negishi K. Inhibition of DNA adduct formation and mutagenic action of 3-amino-1-methyl-5h-pyrido[4,3-b]indole by chlorophyllin-chitosan in rpsL transgenic mice. Jpn J Cancer Res 2001, 92:848-853.
181. Elbling L., Weiss R.M., Teufelhofer O., Uhl M., Knasmûller S., Schulte-Hermann R., Berger W., Micksche M. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. Faseb J 2005, 19:807-809.
182. Steinmetz K.A., Potter J.D. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991, 2:427-442.
183. Wollowski I., Rechkemmer G., Pool-Zobel B.L. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001, 73:451S-455S.